Furthermore, In CESC, KICH, KIRP, LGG, MESO, and UVM, increased TMED2 expression was associated with decreased disease-specific survival (DSS) (Supplementary Figure S3H). Here, TMED2 is linked to cervical squamous cell carcinoma.